Work

Combining cancer immunotherapy and targeted therapy

Year: 2013

Type: review

Source: Current Opinion in Immunology

DOI: 10.1016/j.coi.2013.02.011

Authors: Antoni Ribas, Jedd D Wolchok

Institutions: University of California, Los Angeles, Memorial Sloan Kettering Cancer Center, Ludwig Cancer Research

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Breast Cancer Research Foundation, Melanoma Research Alliance, Lita Annenberg Hazen Foundation, National Institutes of Health, National Cancer Institute, Jonsson Cancer Center Foundation

Awards: Defining the Importance of Immunity to NY-ESO-1 in Melanoma Therapy and Prognosis, G2569924271, G3049806640, The UCLA Center for In Vivo Imaging in Cancer Biology, G445550, NanoSystems Biology Cancer Center, Stem Cell-Engineered Tumor Immunity in Man, Strategies for Distinguishing Success in Immunotherapy Treatments (PQ20), Immunization Against Melanoma Differentiation Antigens

OpenAlex ID: W2039475508

FWCI: 1.237

Cites: 55

Cited by: 64

Related to: 10